Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Dosage Regimen: Fixed Dose

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Relevance of the KATP channel function for the basal insulin hypersecretion of islets from female NZO mice.

Journal of the Endocrine Society·2026

Same author

The Amount of Releasable Insulin Depends on Continuous Oxidative Phosphorylation.

Function (Oxford, England)·2025

Same author

Obituary: Arnold Hasselblatt (1929 - 2024).

Naunyn-Schmiedeberg's archives of pharmacology·2025

Same author

The Proton Leak of the Inner Mitochondrial Membrane Is Enlarged in Freshly Isolated Pancreatic Islets.

Biomedicines·2024

Same author

Short-Term Inhibition of Translation by Cycloheximide Concurrently Affects Mitochondrial Function and Insulin Secretion in Islets from Female Mice.

International journal of molecular sciences·2023

Same author

PyCreas: a tool for quantification of localization and distribution of endocrine cell types in the islets of Langerhans.

Frontiers in endocrinology·2023

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

[Fixed drug combinations--the pros and the cons].

Ingo Rustenbeck¹

¹Institut für Pharmakologie und Toxikologie der TU Braunschweig, Mendelssohnstrasse 1,38106 Braunschweig. i.rustenbeck@tu-bs.de

Medizinische Monatsschrift Fur Pharmazeuten

|May 19, 2009

Summary

Fixed-dose combination drugs may improve patient compliance and clinical outcomes for chronic diseases by reducing daily pill intake. However, evidence is limited, requiring separate evaluations for efficacy, safety, and cost-effectiveness.

Area of Science:

Pharmacology
Clinical Medicine
Health Economics

Context:

Many chronic diseases, including hypertension, type 2 diabetes mellitus, allergic asthma, tuberculosis, and AIDS, necessitate combination drug therapy for effective treatment.
The increasing prevalence of multimorbidity, particularly in older adults, leads to complex medication regimens and potential challenges with patient adherence.
Fixed-dose combination (FDC) therapies offer a strategy to simplify medication schedules by consolidating multiple drugs into a single dosage form.

Purpose:

To explore the potential benefits of fixed-dose combination drugs in improving patient compliance and clinical outcomes.
To highlight the need for rigorous evaluation of FDCs regarding efficacy, safety, and pharmacoeconomic aspects.
To emphasize that the utility of FDCs must be assessed on a disease-specific basis.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Experiment Videos

Last Updated: Jun 23, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Summary:

Combination drug therapy is essential for managing numerous chronic and infectious diseases.
Fixed-dose combinations (FDCs) may enhance patient adherence and therapeutic results by reducing the number of daily drug intakes.
However, robust evidence supporting the general efficacy of FDCs is scarce, necessitating individual assessments for each condition.

Impact:

FDCs have the potential to improve treatment adherence and clinical endpoints in chronic disease management.
Separate evaluations are crucial to determine the specific benefits and risks of FDCs for different diseases.
Pharmacoeconomic analyses are essential to compare the cost-effectiveness of FDCs against free combinations.